LRRC46
Leucine-rich repeat-containing protein 46
Also known as: LRC46_HUMAN, MGC16309
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96FV0
- Gene
- LRRC46
- Ensembl
- ENSG00000141294
- Chromosome
- 17
- Canonical length
- 321 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nuclear bodies,Plasma membrane,Primary cilium,Basal body
OverviewNCBI Gene
Predicted to be involved in sperm flagellum assembly. Predicted to act upstream of or within maintenance of cell number; single fertilization; and sperm flagellum assembly. Predicted to be active in sperm midpiece. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
321 residues, UniProt reviewed canonical sequence.
>Q96FV0|LRRC46
1 MSGGKSAQGP EEGGVCITEA LITKRNLTFP EDGELSEKMF HTLDELQTVR LDREGITTIR
61 NLEGLQNLHS LYLQGNKIQQ IENLACIPSL RFLSLAGNQI RQVENLLDLP CLQFLDLSEN
121 LIETLKLDEF PQSLLILNLS GNSCTNQDGY RELVTEALPL LLDLDGQPVV ERWISDEEDE
181 ASSDEEFPEL SGPFCSERGF LKELEQELSR HREHRQQTAL TEHLLRMEMQ PTLTDLPLLP
241 GVPMAGDSSP SATPAQGEET VPEAVSSPQA SSPTKKPCSL IPRGHQSSFW GRKGARAATA
301 PKASVAEAPS TTKTTAKRSK KLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LRRC46 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 74 nTPM
Expression across tissuesHPA
Tissue
- fallopian tube: 74 nTPM
- testis: 49 nTPM
- choroid plexus: 17 nTPM
- lung: 5 nTPM
- hypothalamus: 4.2 nTPM
- hippocampal formation: 3.5 nTPM
Single-cell type
- fallopian tube ciliated cells: 393 nCPM
- respiratory ciliated cells: 318 nCPM
- late primary spermatocytes: 306 nCPM
- epididymal efferent duct ciliated cells: 184 nCPM
- endometrial ciliated cells: 171 nCPM
- early spermatids: 127 nCPM
Immune cell
- basophil: 1.3 nTPM
- NK-cell: 0.8 nTPM
- myeloid DC: 0.7 nTPM
- eosinophil: 0.5 nTPM
- intermediate monocyte: 0.5 nTPM
- neutrophil: 0.5 nTPM
Brain region
- midbrain: 14 nTPM
- choroid plexus: 8.7 nTPM
- medulla oblongata: 6.4 nTPM
- spinal cord: 6.3 nTPM
- pons: 4.2 nTPM
- white matter: 3.9 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about LRRC46.
Disease | ImmuneIEDB
Conditions an epitope on LRRC46 was assayed in.
- hepatocellular carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.92
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.85
- DepMap mean gene effect
- -0.15
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- maintenance of cell number
- single fertilization
- sperm axoneme assembly
- sperm flagellum assembly
- sperm mitochondrial sheath assembly
- spermatogenesis
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LRRC46 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LRRC46 as an antibody target. Whether an autoantibody or antibody against LRRC46 could matter depends on whether native LRRC46 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LRRC46 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LRRC46 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...